ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2026 earnings release and conference ...

Medical device company ICU Medical (NASDAQ:ICUI) reported Q1 CY2025 results , with sales up 6.7% year on year to $604.7 million. Its non-GAAP profit of $1.72 per share was 34.4% above analysts’ ...

Medical device company ICU Medical (NASDAQ:ICUI) reported Q4 CY2024 results , with sales up 7.1% year on year to $629.8 million. Its non-GAAP profit of $2.11 per share was 42.4% above analysts’ ...

ICU Medical Inc., a supplier of infusion therapy-related medical equipment, reported fourth quarter revenue and profit that topped analysts’ expectations. Yet, investors are unhappy, sending the stock ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

ICU Medical's deal with Smiths Medical is underperforming, following a previous troubled deal with Hospira Infusion Systems. Shares have fallen by 50% over the past two years, as the company's outlook ...

ICU Medical Inc. Chief Executive Vivek Jain said the company’s second-quarter results were “generally in line with our expectations.” However, it wasn’t what Wall Street was expecting. Second-quarter ...

ICU Medical will release Q1 2025 earnings on May 8, followed by a conference call at 4:30 p.m. ET. ICU Medical, Inc. announced its first quarter 2025 earnings release and conference call, scheduled ...

A recall of nearly 62,800 replacement batteries used in several of ICU Medical’s infusion pumps has received the FDA’s Class I rating—the agency’s most serious, denoting a higher risk of serious ...

ICU Medical, Inc. is positioned for margin expansion as Smiths Medical integration and remediation costs subside. Learn more ...